Shares of Valeant Pharmaceuticals International, Inc. (TSE:VRX – Get Free Report) (NYSE:VRX) fell 3.3% during trading on Monday . The company traded as low as C$30.75 and last traded at C$30.80. 1,232,408 shares traded hands during mid-day trading, a decline of 11% from the average session volume of 1,382,994 shares. The stock had previously closed at C$31.86.
Valeant Pharmaceuticals International Price Performance
The firm has a fifty day moving average of C$30.80.
Valeant Pharmaceuticals International Company Profile
Valeant Pharmaceuticals International, Inc operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S.
Further Reading
- Five stocks we like better than Valeant Pharmaceuticals International
- The Significance of Brokerage Rankings in Stock Selection
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- What is the Australian Securities Exchange (ASX)
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Valeant Pharmaceuticals International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals International and related companies with MarketBeat.com's FREE daily email newsletter.